Association Between Urine Concentration Ability and the Progression of Chronic Kidney Disease
1 other identifier
observational
200
1 country
1
Brief Summary
The study hypothesis is that urine concentrating ability can predict the rate of kidney function decline. Patients with kidney disease at the investigatorsclinic will be asked to give first morning urine sample and osmolarity will be measured. The investigators will follow up kidney function decline and check if there is association with urine osmolarity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2011
CompletedFirst Posted
Study publicly available on registry
August 25, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedAugust 25, 2011
August 1, 2011
2 years
August 23, 2011
August 24, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
eGFR slope
Creatinnie value will be measured at least every three month and eGFR will be calculated by MDRD equation. A regression line will be plotted against time and the eGFR slope will be calculated.
12 month
Eligibility Criteria
Patients with CKD and estimated GFR of less then 50 mL per minute.
You may qualify if:
- Patients with CKD and estimated GFR of less then 50 mL per minute estimated by the short MDRD equation base on two creatinine values taken at least two weeks apart and are not getting steroids or immunosuppressive medication as treatment for their primary kidney disease.
You may not qualify if:
- Life expectancy of less then 6 month.
- Expected to start renal replacement therapy within 3 month.
- Acute or acute on chronic renal failure with reversible component.
- Treatment with AVP inhibitors.
- Chronic hyponatremia (Na+\<135 in two measurement two weeks apart).
- Primary polydipsia.
- Inability to give informed consent.
- Clinical hypovolemia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benaya Rozen-Zvilead
Study Sites (1)
Pre dialysis clinic Dan Petach Tiqua county General health service
Ganey Tiqua, 55900, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benaya Rozen-Zvi, MD
General health services - Dan Petach tiqua county
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- attending nephrologist pre dialysis clinic Dan petach-tiqua county
Study Record Dates
First Submitted
August 23, 2011
First Posted
August 25, 2011
Study Start
October 1, 2011
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
August 25, 2011
Record last verified: 2011-08